AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Genetic targets for the prediction, diagnosis, and treatment of IgA nephropathy

Summary
This technology is a diagnostic tool to assess patients’ risk of IgA nephropathy based on the presence or absence of seven specific alleles.
Technology Benefits
Non-invasive assay doesn’t require a renal biopsyQuantitative risk assessmentIdentifies novel targets for future therapeuticsSimple to implement in a clinical setting
Technology Application
Non-invasive diagnostic assay for IgA nephropathyTherapeutic targets for IgA nephropathyResearch tool for studying the genetic mechanism of IgA nephropathy pathology
Detailed Technology Description
None
*Abstract
None
*Inquiry
Jerry KokoshkaColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
*IR
2798
*Principal Investigator
*Publications
Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, et al. “Genome-wide association study identifies susceptibility loci for IgA nephropathy.” Nature Genetics. 2011 Mar 13;43(4): 321-7.Tech Ventures Reference:IR 2798Licensing Contact: Jerry Kokoshka
Country/Region
USA

For more information, please click Here
Mobile Device